Koa Shoji Holdings Co., Ltd. engages in the manufacture, stock and sale of pharmaceutical ingredient and pharmaceuticals. It operates through the Drug Substance Sales and Pharmaceutical Manufacturing and Sales segments. The Drug Substance Sales segment imports and sells raw materials for drugs. The Pharmaceutical Manufacturing and Sales segment manufactures and sells prescription pharmaceuticals and drugs for general use. The company was founded on January 30, 2015 and is headquartered in Yokohama, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company